Rating
Sell
Price target
$17
Previous
$20
Implied downside
-5%

Barclays analyst Jiong Shao lowered the price target on XPeng (NYSE: XPEV) to $17.00 (from $20.00) while maintaining a Underweight rating.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Previous notes from Barclays on XPeng

Barclays Sell Lowers targetMar 23, 2026 $16from $17

Other XPeng notes

Goldman SachsBuy Lowers target · Aug 3, 2026 $20from $23 JP MorganBuy Note · Jul 14, 2026 maintained BernsteinHold Reiterate · Jun 17, 2026 maintained BernsteinHold Reiterate · Jun 17, 2026 from $22 MacquarieBuy Upgrade · Jun 1, 2026 $73maintained

Share on